BETA is attending and reporting from the 2017 International AIDS Society conference on HIV Science this week in Paris, France from July 23 to 26—bringing you the latest news, updates, and research on HIV treatment and prevention.
As countries, cities and agencies worldwide ramp up their investment in pre-exposure prophylaxis (PrEP) services for people at risk for HIV, many are wondering: Is this strategy working in the “real world”—outside the safe parameters of clinical trials?
At the International AIDS Society conference this week, three researchers offered evidence to this point. Here’s what we learned about how the scale-up of PrEP health services (along with other PrEP awareness and educational campaigns) is helping to reduce the number of new HIV infections in communities and countries around the world.
